This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Melbourne. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Derek Lacey
Introduction
Derek Lacey is a notable inventor based in Melbourne, Australia. He has made significant strides in the field of pain management through his innovative research and development. His work focuses on the treatment of pain using specific antibodies, showcasing his commitment to improving healthcare outcomes.
Latest Patents
Derek Lacey holds 1 patent for a method of treatment of pain by administration of a CCL17 specific antibody. This patent outlines a protocol for pain management that includes a pharmaceutical composition aimed at ameliorating the sensation of pain. The protocol incorporates the use of a CCL17 signaling antagonist, either alone or in combination with another analgesic compound, to effectively treat pain associated with inflammatory conditions. The CCL17 signaling antagonist consists of an antibody or an antigen-binding derivative that binds to CCL17 or its receptor.
Career Highlights
Derek Lacey is affiliated with The University of Melbourne, where he contributes to research and development in the medical field. His work is pivotal in advancing the understanding of pain management and the therapeutic applications of antibodies.
Collaborations
Derek collaborates with esteemed colleagues, including Andrew David Cook and John Allan Hamilton. Their combined expertise enhances the research efforts at The University of Melbourne, fostering an environment of innovation and discovery.
Conclusion
Derek Lacey's contributions to pain management through his innovative patent reflect his dedication to improving patient care. His work at The University of Melbourne and collaborations with fellow researchers underscore the importance of teamwork in advancing medical science.